Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 8, 2011, Pages 5559-5564

  Lake, Sarah L ^a   Damato, Bertil E ^b   Dopierala, Justyna ^a   Baudo, Maria M ^a   Taktak, Azzam F G ^c   Coupland, Sarah E ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Liverpool Ocular Oncology Service   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 1P; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISOMY; EXTRAOCULAR MUSCLE; EYE BIOPSY; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOCULAR TUMOR; MALE; MONOSOMY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UVEA MELANOMA; BIOPSY; CHROMOSOME 1; DNA PROBE; GENE DOSAGE; GENETIC MARKER; GENETICS; MELANOMA; METHODOLOGY; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; PATHOLOGY; PROGNOSIS; UVEA TUMOR;

AGED; AGED, 80 AND OVER; BIOPSY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; DNA PROBES; FEMALE; GENE DOSAGE; GENETIC HETEROGENEITY; GENETIC MARKERS; HUMANS; MALE; MELANOMA; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROGNOSIS; UVEAL NEOPLASMS;

EID: 80053317672     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6845     Document Type: Article

References (43)

1. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114:1925-1931.
2. Damato BE, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland S. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci. 2009;50:3048-3055.
3. Mensink HW, Kilic E, Vaarwater J, Douben H, Paridaens D, de Klein A. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet. 2008;181: 108-111.
4. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222-1225.
5. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41:215-228.
6. Shields CL, Shields JA. Ocular melanoma: relatively rare but requiring respect. Clin Dermatol. 2009;27:122-133.
7. Bellmann C, Lumbroso-Le Rouic L, Levy C, et al. Uveal melanoma: management and outcome of patients with extraocular spread. Br J Ophthalmol. 2010;94:569-574.
8. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115:1778-1785.
9. Pach JM, Robertson DM, Taney BS, Martin JA, Campbell RJ, O'Brien PC. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension. Am J Ophthalmol. 1986;101:325-331.
10. Shammas HF, Blodi FC. Orbital extension of choroidal and ciliary body melanomas. Arch Ophthalmol. 1977;95:2002-2005.
11. Greer CH, Buckley C, Buckley J, Ramsay R, La Nauze L. An Australian choroidal melanoma survey: factors affecting survival following enucleation. Aust J Ophthalmol. 1981;9:255-261.
12. Kidd MN, Lyness RW, Patterson CC, Johnston PB, Archer DB. Prognostic factors in malignant melanoma of the choroid: a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980. Trans Ophthalmol Soc U K. 1986;105(pt 1):114-121.
13. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983;101:1894-1899.
14. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet. 1990;45:249-253.
15. Prescher G, Bornfeld N, Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst. 1990;82:1765-1769.
16. Cook SA, Damato B, Marshall E, Salmon P. Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye. 2009;23:581-585.
17. Damato B, Coupland SE. Managing patients with ocular melanoma: state of the art. Clin Exp Ophthalmol. 2008;36:589-590.
18. Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE. Genetic heterogeneity in uveal melanoma assessed by multiplex ligationdependent probe amplification. Invest Ophthalmol Vis Sci. 2010;51:4898-4905.
19. Maat W, Jordanova ES, van Zelderen-Bhola SL, et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med. 2007;131:91-96.
20. Meir T, Zeschnigk M, Masshofer L, Pe'er J, Chowers I. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma. Invest Ophthalmol Vis Sci. 2007;48: 1918-1922.
21. Mensink HW, Vaarwater J, Kilic E, et al. Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci. 2009;50:500-504.
22. Sandinha T, Farquharson M, McKay I, Roberts F. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type. Invest Ophthalmol Vis Sci. 2006;47:5177-5180.
23. Lake SL, Coupland SE, Taktak AF, Damato BE. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51:4884-4891.
24. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
25. Damato BE, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res. 2010;16:6083-6092.
26. Kivelä T, Harbour JW, Coupland SE, et al. Malignant melanoma of the uvea. In: Edge SE, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer. 2010:547-553.
27. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96:502-509.
28. Schoenfield L, Pettay J, Tubbs RR, Singh AD. Variation of monosomy3 status within uveal melanoma. Arch Pathol Lab Med. 2009;133:1219-1222.
29. Ehlers JP, Worley L, Onken MD, Harbour JW. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res. 2005;11:3609-3613.
30. Singh AD, Tubbs R, Biscotti C, Schoenfield L, Trizzoi P. Chromosomal3 and 8 status within hepatic metastasis of uveal melanoma. Arch Pathol Lab Med. 2009;133:1223-1227.
31. Kilic E, van Gils W, Lodder E, et al. Clinical and cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci. 2006;47: 3703-3707.
32. Prescher G, Bornfeld N, Friedrichs W, Seeber S, Becher R. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation. Cancer Genet Cytogenet. 1995;80:40-46.
33. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 1998;83:354-359.
34. Bonaldi L, Midena E, Filippi B, et al. FISH analysis of chromosomes3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol. 2008;134:1123-1127.
35. Hoglund M, Gisselsson D, Hansen GB, et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer. 2004;108:57-65.
36. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res. 1999;59:3032-3037.
37. Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res. 2007;13:2923-2927.
38. Trolet J, Hupe P, Huon I, et al. Genomic profiling and identification of high risk uveal melanoma by array-CGH analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci. 2009;50: 2572-2580.
39. Cross NA, Ganesh A, Parpia M, Murray AK, Rennie IG, Sisley K. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye. 2006;20:476-481.
40. Blasi MA, Roccella F, Balestrazzi E, et al. 3p13 region: a possible location of a tumor suppressor gene involved in uveal melanoma. Cancer Genet Cytogenet. 1999;108:81-83.
41. Parrella P, Fazio VM, Gallo AP, Sidransky D, Merbs SL. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res. 2003;63:8507-8510.
42. Tschentscher F, Prescher G, Horsman DE, et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res. 2001;61:3439-3442.
43. Eleuteri ADB, Coupland SE, Taktak AFG. Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. Int J Biomed Eng Tech. In press.